Cultures in PICU Patients Compared to Healthy Children

Ventilator Associated Pneumonia Clinical Trial

Official title:

Oral and Tracheal Cultures in Pediatric ICU Patients Compared to Healthy Children

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03418272
• Other study ID #: STUDY00001954
• Status: Withdrawn
• Start date: February 2023
• Est. completion date: September 2023

Study information

• Verified date: April 2022
• Source: State University of New York at Buffalo
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is being done to determine if the bacteria found in your mouth (oral flora bacteria) in children admitted to the intensive care unit who need to be on a breathing machine is different from the oral flora in healthy children undergoing anesthesia for their dental caries. Children in the intensive care unit with a breathing tube are at a higher risk for getting a lung infection due to the bacteria in the mouth slipping into their lungs past the breathing tube over several days. This means that bacteria are found in the child's lung when this is normally not the case. If the bacteria in the mouth have changed from normal then they may get a pneumonia.

Description:

The oral cavity has natural flora of microbiology that may be associated with the development of dental decay. Another possible problem arising from this flora is the migration of the bacteria into the trachea causing pulmonary infections such as trachietis or pneumonia. The risk of developing a pulmonary infection appears to be increased in patients who have been intubated for a period of time (days) such as those patients ventilated in the intensive care unit (ICU). It has also been shown that in patients in the ICU the nature of the oral flora changes over time to include bacteria that are more commonly associated with the nosocomial pneumonia, ventilator associated pneumonia. We have previous demonstrated in a small pilot study (CYIRB2779) that the changes in the oral flora in children intubated in the ICU was similar to those bacteria grown from tracheal cultures ordered by the intensivist. Patients intubated in the ICU maybe at risk of decreased salivary flow, sedated and unable to clear secretions and are reliant on the bedside nurse to maintain adequate oral hygiene. Most ICU's have guidelines and policies to ensure that oral hygiene is appropriately cared for. They are also at risk for changes in the oral flora due to concomitant broad-spectrum antibiotic use that is common in the initial 48 hours after admission with respiratory failure.

The second are of interest is to determine whether children who are very sick and require intubation and ventilation support have different bugs growing in their mouth that may predispose them to future infection whilst in the ICU.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2023
• Est. primary completion date: May 2023
• Gender: All
• Age group: 2 Years to 8 Years

Eligibility

Inclusion Criteria:

ICU Group:

• Intubated within 12 hours

• ASA 1 or 2 (ASA - AMERICAN SOCIETY ANESTEHESIOLOGY PREOPOERATIVE STATUS)

• Age 2 to 8

OR Group:

• ASA 1 or 2

• Elective dental surgery requiring intubation

• Age 2 to 8

Exclusion Criteria:

ICU Group:

• Trauma patients

• Postoperative patients

• Children under 2 or over 8

OR Group:

• Received antibiotics within the last week

• Received prednisone within the last 2 weeks

• Viral respiratory infective process within the last 2 weeks

Related Conditions & MeSH terms

• Pneumonia
• Pneumonia, Bacterial
• Pneumonia, Ventilator-Associated
• Ventilator Associated Pneumonia

Intervention

Diagnostic Test:
• Culture/PCR Analysis
Microbes to be selectively cultured and PCR analysis to be conducted. Bacteria obtained in samples will be dispersed in non-selective Mueller Hinton Broth (Sigma-Aldrich), divided into two separate cultures and grown overnight at 37°C in aerobic condition and in 5% CO2 to assure survival of both aerobic and facultative anaerobic species. Staphylococcus aureus (MSSA, MRSA) Pseudomonas aeruginosa Haemophilus influenza Streptococcus pneumonia Streptococcus Pyogenes Group B streptococci, Klebsiella pneumonia Moraxella catarrhalis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York at Buffalo

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of bacteria in sample	PCR analysis	By January 2019
Primary	Presence of bacteria in sample	Culture analysis	By January 2019